Skip to content
Screener

Pacific Biosciences of California PACB Americas — Total Revenue

Other geography segments

Europe, Middle East and Africa
$14.43M+52.4%
Asia-Pacific
$6.96M-44.8%

Similar metrics at other companies

Arlo Technologies logo
ARLOAmericas — Total Revenue
$88.97M+8.6%
Weatherford International logo
WFRDLatin America — Total Revenue
$197M+1.0%
Weatherford International logo
WFRDNorth America — Total Revenue
$205M-14.9%
Cohen & Steers logo
CNSNorth America — Total Revenue
$127.76M+8.9%
Ciena logo
CIENAmericas — Total Revenue
$1.2B+44.2%
MongoDB logo
MDBAmericas — Total Revenue
$412.34M+23.9%

Other financials

Income statement

See full
Revenue$39.0M-1.9%
Gross profit$12.6M-13.9%
Operating income-$44.6M+0.5%
Net income-$44.7M-6.7%
EPS (diluted)-$0.140.0%

Balance sheet

See full
Cash & equivalents$62.6M+10.5%
Total debt$61.8M+17.1%
Total equity-$33.2M-154%
Total assets$751.9M-8.9%

Cash flow

See full
Operating cash flow-$35.6M-21.1%
CapEx$1.6M+183%
Free cash flow-$37.1M-24.1%

Valuation

See full
Market cap$357.46M-5.6%
Enterprise value$356.64M-4.8%
P/S2.2×-0.2×

Profitability

See full
Gross margin36.4%+15.0pp
Operating margin-83.5%-37.4pp
Net margin-82.5%-35.5pp
FCF margin-77.5%-13.2pp

Returns & leverage

See full
Return on equity-273.6%+314pp
Debt / equity25.1×+24.5×
Current ratio4.9×-2.0×

Where this comes from

Reported directly by Pacific Biosciences of California in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The source filing: Pacific Biosciences of California’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:30 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001299130-26-000122
(In thousands)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Americas$17,624$17,687$34,309$33,990
Europe, Middle East and Africa14,4269,46725,19518,707
Asia-Pacific6,95712,61216,68124,222
Total revenue$39,007$39,766$76,185$76,919

Item 1. Financial Statements (unaudited):

FAQ

What is Pacific Biosciences of California's americas — total revenue?
Pacific Biosciences of California (PACB) reported americas — total revenue of $17.62M in Q2 2026.
How has Pacific Biosciences of California's americas — total revenue changed year-over-year?
Pacific Biosciences of California's americas — total revenue decreased by 0.4% year-over-year, from $17.69M to $17.62M.
What is the long-term trend for Pacific Biosciences of California's americas — total revenue?
Over 3 years (2022 to 2025), Pacific Biosciences of California's americas — total revenue has grown at a 1.5% compound annual growth rate (CAGR), from $69.56M to $72.8M.
What does americas — total revenue mean?
This metric represents the total gross revenue generated from the sale of products and services within the Americas geographic region. It serves as a key indicator of market penetration and demand for genetic sequencing platforms in this specific territory. Tracking this figure helps investors assess the company's regional growth trajectory and its ability to capture market share in its primary commercial hub.

Ask your AI about Pacific Biosciences of California's americas — total revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude